HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ford, P. W. Articles by Akula, S. M. Search for Related Content PubMed PubMed Citation Articles by Ford, P. W. Articles by Akula, S. M. Agricola Articles by Ford, P. W. Articles by Akula, S. M.

Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency

¹ Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA
² Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA

Correspondence
Shaw M. Akula
akulas{at}mail.ecu.edu

Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. KSHV infection of cells produces both latent and lytic cycles of infection. In vivo, the virus is found predominantly in the latent state. In vitro, a lytic infection can be induced in KSHV-infected cells by treating with phorbol ester (TPA). However, the exact signalling events that lead to the reactivation of KSHV lytic infection are still elusive. Here, a role is demonstrated for B-Raf/MEK/ERK signalling in TPA-induced reactivation of KSHV latent infection. Inhibiting MEK/ERK signalling by using MEK-specific inhibitors decreased expression of the TPA-induced KSHV lytic-cycle gene ORF8. Transfection of BCBL-1 cells with B-Raf small interfering RNA inhibited TPA-induced KSHV lytic infection significantly. Additionally, overexpression of MEK1 induced a lytic cycle of KSHV infection in BCBL-1 cells. The significance of these findings in understanding the biology of KSHV-associated pathogenesis is discussed.

This article has been cited by other articles:

				E. Kuang, F. Wu, and F. Zhu Mechanism of Sustained Activation of Ribosomal S6 Kinase (RSK) and ERK by Kaposi Sarcoma-associated Herpesvirus ORF45: MULTIPROTEIN COMPLEXES RETAIN ACTIVE PHOSPHORYLATED ERK AND RSK AND PROTECT THEM FROM DEPHOSPHORYLATION J. Biol. Chem., May 15, 2009; 284(20): 13958 - 13968. [Abstract] [Full Text] [PDF]

				L. M. Gargano, J. C. Forrest, and S. H. Speck Signaling through Toll-Like Receptors Induces Murine Gammaherpesvirus 68 Reactivation In Vivo J. Virol., February 1, 2009; 83(3): 1474 - 1482. [Abstract] [Full Text] [PDF]

				J. E. Strong, G. Wong, S. E. Jones, A. Grolla, S. Theriault, G. P. Kobinger, and H. Feldmann Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway PNAS, November 18, 2008; 105(46): 17982 - 17987. [Abstract] [Full Text] [PDF]

				E. Kuang, Q. Tang, G. G. Maul, and F. Zhu Activation of p90 Ribosomal S6 Kinase by ORF45 of Kaposi's Sarcoma-Associated Herpesvirus and Its Role in Viral Lytic Replication J. Virol., February 15, 2008; 82(4): 1838 - 1850. [Abstract] [Full Text] [PDF]

				Y. Zeng, X. Zhang, Z. Huang, L. Cheng, S. Yao, D. Qin, X. Chen, Q. Tang, Z. Lv, L. Zhang, et al. Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling J. Virol., March 1, 2007; 81(5): 2401 - 2417. [Abstract] [Full Text] [PDF]

				A. G. Whitman, O. F. Dyson, P. J. Lambert, T. L. Oxendine, P. W. Ford, and S. M. Akula Changes occurring on the cell surface during KSHV reactivation J. Electron Microsc. (Tokyo), January 1, 2007; 56(1): 27 - 36. [Abstract] [Full Text] [PDF]